Browse HCPCS Level II 2020 Edition

HCPCS Level II Table of Contents

Q5111 - Q5118  new group

Q5111
Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg
shortInjection, udenyca 0.5 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
MUE
LocationValueAjudication IndicatorRationale
PRA12.03 Date of Service Edit: ClinicalPrescribing Information
OPH12.03 Date of Service Edit: ClinicalPrescribing Information
DME0.03 Date of Service Edit: ClinicalCMS Policy
Q5112
Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
shortInj ontruzant 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
MUE
LocationValueAjudication IndicatorRationale
PRA120.03 Date of Service Edit: ClinicalPrescribing Information
OPH120.03 Date of Service Edit: ClinicalPrescribing Information
Q5113
Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
shortInj herzuma 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
MUE
LocationValueAjudication IndicatorRationale
PRA120.03 Date of Service Edit: ClinicalClinical: Society Comment
OPH120.03 Date of Service Edit: ClinicalClinical: Society Comment
Q5114
Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
shortInj ogivri 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
MUE
LocationValueAjudication IndicatorRationale
PRA120.03 Date of Service Edit: ClinicalPrescribing Information
OPH120.03 Date of Service Edit: ClinicalPrescribing Information
Q5115
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
shortInj truxima 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
MUE
LocationValueAjudication IndicatorRationale
PRA120.03 Date of Service Edit: ClinicalPrescribing Information
OPH120.03 Date of Service Edit: ClinicalPrescribing Information
Q5116
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
shortInj., trazimera, 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
Q5117
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
shortInj., kanjinti, 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX
Q5118
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
shortInj., zirabev, 10 mg
RVU
CPT ModifierPhysician ComponentFacility PracticeNonfacility PracticeProfessional Liability InsuranceTotal FacilityTotal NonfacilityGlobal Period
0.00.00.00.00.00.0XXX